{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:38:25Z","timestamp":1768070305532,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,12]],"date-time":"2009-10-12T00:00:00Z","timestamp":1255305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Adiponectin is a major adipocyte-derived protein with insulin-sensitizing, anti-inflammatory and anti-atherogenic properties. Adiponectin levels correlate inversely with renal function and higher levels are predictive of lower cardiovascular disease (CVD) in patients with normal renal function and chronic kidney disease. No data exists on the association between adiponectin and CVD in renal transplant recipients (RTR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Standard biochemistry, clinical data and adiponectin were collected from 137 RTR recruited to the LANDMARK 2 study at baseline. The LANDMARK 2 study is an ongoing randomized controlled study that compares the outcome of aggressive risk factor modification for cardiovascular disease versus standard post-transplant care in renal transplant recipients with impaired glucose tolerance or diabetes mellitus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Mean patient age was 53.4 \u00b1 12 years and the median post-transplantation period was 5 (0.5-31.9) years. Mean serum adiponectin level was 12.3 \u00b1 7.1 \u03bcg\/mL. On univariate analysis, adiponectin was positively associated with female gender (P = 0.01) and serum high-density lipoprotein (HDL) concentration (P &lt; 0.001), and inversely with body mass index (P = 0.009), metabolic syndrome (P = 0.047), abnormal glucose tolerance (P = 0.01), C-reactive protein (P = 0.001) and serum triglyceride (P &lt; 0.001). On stepwise multivariate analysis, adiponectin in males was negatively correlated with combined baseline CVD (P = 0.03), waist-hip ratio (P = 0.003) and glomerular filtration rate (P = 0.046), and positively with HDL (P &lt; 0.001). In contrast, in females adiponectin was inversely associated with C-reactive protein (P = 0.001) and serum triglyceride.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In conclusion, adiponectin is positively correlated with inflammation, dyslipidemia and abnormal glucose tolerance in RTR. Furthermore, hypoadiponectinemia correlated with increased baseline CVD in male RTR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-10-29","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T06:15:08Z","timestamp":1255414508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study"],"prefix":"10.1186","volume":"10","author":[{"given":"Mohd O","family":"Kaisar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mudge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,12]]},"reference":[{"issue":"4","key":"138_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.semnephrol.2007.03.005","volume":"27","author":"PT Pham","year":"2007","unstructured":"Pham PT, Pham PC, Donovitch GM: Cardiovascular disease posttransplant. Semin Nephrol. 2007, 27 (4): 430-44. 10.1016\/j.semnephrol.2007.03.005.","journal-title":"Semin Nephrol"},{"issue":"3","key":"138_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1586\/14779072.3.3.465","volume":"3","author":"KR Rabin","year":"2005","unstructured":"Rabin KR, Kamari Y, Avni I, Grossman E, Sharabi Y: Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther. 2005, 3 (3): 465-471. 10.1586\/14779072.3.3.465.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"138_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2337\/dc05-1801","volume":"29","author":"K Hara","year":"2006","unstructured":"Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006, 29 (6): 1357-1362. 10.2337\/dc05-1801.","journal-title":"Diabetes Care"},{"issue":"3","key":"138_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","volume":"8","author":"JP Whitehead","year":"2006","unstructured":"Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006, 8 (3): 264-280. 10.1111\/j.1463-1326.2005.00510.x.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"138_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20 (6): 1595-1599.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"138_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/01.HYP.0000169444.05588.4c","volume":"45","author":"Y Iwashima","year":"2005","unstructured":"Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005, 45 (6): 1094-1100. 10.1161\/01.HYP.0000169444.05588.4c.","journal-title":"Hypertension"},{"issue":"5-6","key":"138_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.thromres.2003.08.004","volume":"110","author":"Z Dzieli\u00f1ska","year":"2003","unstructured":"Dzieli\u00f1ska Z, Januszewicz A, Wiecek A, Demkow M, Makowiecka-Cie\u015bla M, Prejbisz A, Kadziela J, Mielniczuk R, Florczak E, Janas J, Januszewicz M, Ruzy\u0142\u0142o W: Decreased plasma concentration of a novel anti-inflammatory protein adiponectin in hypertensive men with coronary artery disease. Thromb Res. 2003, 110 (5-6): 365-369. 10.1016\/j.thromres.2003.08.004.","journal-title":"Thromb Res"},{"key":"138_CR8","doi-asserted-by":"crossref","unstructured":"Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, Catalano F, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003, S98-102. 10.1046\/j.1523-1755.63.s84.49.x. 84","DOI":"10.1046\/j.1523-1755.63.s84.49.x"},{"issue":"1","key":"138_CR9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002, 13 (1): 134-141.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"138_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1681\/ASN.2004090742","volume":"16","author":"B Becker","year":"2005","unstructured":"Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005, 16 (4): 1091-1098. 10.1681\/ASN.2004090742.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"138_CR11","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.amjcard.2006.07.039","volume":"98","author":"Y Iwashima","year":"2006","unstructured":"Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T: Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006, 98 (12): 1603-1608. 10.1016\/j.amjcard.2006.07.039.","journal-title":"Am J Cardiol"},{"issue":"1","key":"138_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.TP.0000132561.48217.B1","volume":"78","author":"B Bayes","year":"2004","unstructured":"Bayes B, Lauzurica R, Granada ML, Serra A, Bonet J, Fontsere N, Salinas I, Romero R: Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation. 2004, 78 (1): 26-30. 10.1097\/01.TP.0000132561.48217.B1.","journal-title":"Transplantation"},{"key":"138_CR13","unstructured":"Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999, Geneva, World Health Organization"},{"key":"138_CR14","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106 (25): 3143-3421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"138_CR15","unstructured":"Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998, 6 (Suppl 2): 51S-209S."},{"issue":"9","key":"138_CR16","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1681\/ASN.2006040331","volume":"17","author":"V Menon","year":"2006","unstructured":"Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (9): 2599-2606. 10.1681\/ASN.2006040331.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"138_CR17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/sj.ki.5002319","volume":"71","author":"C Zoccali","year":"2007","unstructured":"Zoccali C, Mallamaci F: Adiponectin and renal disease progression: another epidemiologic conundrum?. Kidney Int. 2007, 71 (12): 1195-1197. 10.1038\/sj.ki.5002319.","journal-title":"Kidney Int"},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1194\/jlr.M400373-JLR200","volume":"46","author":"Y Fu","year":"2005","unstructured":"Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46: 1369-1379. 10.1194\/jlr.M400373-JLR200.","journal-title":"J Lipid Res"},{"issue":"4","key":"138_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003, 46 (4): 459-469.","journal-title":"Diabetologia"},{"issue":"8","key":"138_CR20","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1210\/jc.2005-0372","volume":"90","author":"CS Mantzoros","year":"2005","unstructured":"Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB: Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005, 90 (8): 4542-4548. 10.1210\/jc.2005-0372.","journal-title":"J Clin Endocrinol Metab"},{"key":"138_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.CIR.0000055188.83694.B3","volume":"107","author":"N Ouchi","year":"2003","unstructured":"Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003, 107: 671-674. 10.1161\/01.CIR.0000055188.83694.B3.","journal-title":"Circulation"},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/diabetes.52.7.1779","volume":"52","author":"PA Kern","year":"2003","unstructured":"Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003, 52: 1779-1785. 10.2337\/diabetes.52.7.1779.","journal-title":"Diabetes"},{"key":"138_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2337\/diacare.26.6.1745","volume":"26","author":"J Krakoff","year":"2003","unstructured":"Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care. 2003, 26: 1745-1751. 10.2337\/diacare.26.6.1745.","journal-title":"Diabetes Care"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","volume":"102","author":"N Ouchi","year":"2000","unstructured":"Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000, 102: 1296-1301.","journal-title":"Circulation"},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI29709","volume":"117","author":"Y Takemura","year":"2007","unstructured":"Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S, Walsh K: Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007, 117: 375-386. 10.1172\/JCI29709.","journal-title":"J Clin Invest"},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1161\/01.CIR.0000018622.84402.FF","volume":"105","author":"Y Arita","year":"2002","unstructured":"Arita Y, Kihara S, Ouchi N, et al: Adipocyte-derived plasma protein, adiponectin, acts as a platelet-derived growth-factor-BB-binding protein and regulates growth factor-induced common post-receptor signal in vascular smooth muscle cell. Circulation. 2002, 105: 2893-2898. 10.1161\/01.CIR.0000018622.84402.FF.","journal-title":"Circulation"},{"key":"138_CR27","doi-asserted-by":"publisher","first-page":"45021","DOI":"10.1074\/jbc.M307878200","volume":"278","author":"H Chen","year":"2003","unstructured":"Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates nitric oxide production in vascular endothelial cells. J Biol Chem. 2003, 278: 45021-45026. 10.1074\/jbc.M307878200.","journal-title":"J Biol Chem"},{"key":"138_CR28","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","volume":"109","author":"M Kumada","year":"2004","unstructured":"Kumada M, Kihara S, Ouchi N, et al: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation. 2004, 109: 2046-2049. 10.1161\/01.CIR.0000127953.98131.ED.","journal-title":"Circulation"},{"key":"138_CR29","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/01.HYP.0000166722.91714.ba","volume":"45","author":"K Koh","year":"2005","unstructured":"Koh K, Quon M, Han S, et al: Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension. 2005, 45: 1088-1093. 10.1161\/01.HYP.0000166722.91714.ba.","journal-title":"Hypertension"},{"key":"138_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000083929","volume":"99","author":"M Yenicesu","year":"2005","unstructured":"Yenicesu M, Yilmaz MI, Caglar K, et al: Blockade of the renin-angiotensin system increases plasma adiponectin concentration in type 2 diabetic patients with proteinuria. Nephron Clin Pract. 2005, 99: 115-121. 10.1159\/000083929.","journal-title":"Nephron Clin Pract"},{"key":"138_CR31","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.2337\/diabetes.51.10.2968","volume":"51","author":"JG Yu","year":"2002","unstructured":"Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinedione on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002, 51: 2968-2974. 10.2337\/diabetes.51.10.2968.","journal-title":"Diabetes"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-10-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:45:27Z","timestamp":1630449927000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-10-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-10-29","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,12]]},"assertion":[{"value":"26 June 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}